Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hanssen

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
Diabetes & Metabolism|February 15, 2020
Fasting and post-oral-glucose-load levels of methylglyoxal are associated with microvascular, but not macrovascular, disease in individuals with and without (pre)diabetes: The Maastricht StudyN M J Hanssen, J L J M Scheijen, A J H M Houben, et al.
Antimicrobial Agents and Chemotherapy|November 13, 2024
Targeted antimicrobial regimens for Gram-negative prosthetic joint infections: a prospective multicenter studyJaap L J Hanssen, Robert J P van der Wal, Rachid Mahdad, et al.
Contemporary Clinical Trials|June 2, 2025
Rifampicin combination therapy versus targeted antimicrobial monotherapy in the oral antimicrobial treatment phase of staphylococcal prosthetic joint infection (RiCOTTA-trial): protocol for a randomized, controlled, open-label, non-inferiority trialJaap L J Hanssen, Esther Y van Hulten, Pieter K Bos, et al.
Circulation Research|June 23, 2020
Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting MyelopoiesisMichelle C Flynn, Michael J Kraakman, Christos Tikellis, et al.
Hepatology Communications|June 11, 2026
Two-step care pathways for advanced MASLD in primary and hospital care: A multicenter studyStan Driessen, Koen C van Son, Tamara R Riemersma, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 16, 2025
Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular DiseaseBernardo Casso-Chapa, Norma Alicia Vazquez González, Nhat-Tu Le, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Downregulation of LATS1/2 Drives Endothelial Senescence-Associated Stemness (SAS) and Atherothrombotic Lesion FormationSivareddy Kotla, Jonghae Lee, Kyung Ae Ko, et al.
Circulation Research|May 27, 2026
LATS1/2-CD38 Metabolic Rewiring Links Senescence to Intraplaque ThrombosisSivareddy Kotla, Jonghae Lee, Kyung Ae Ko, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Diabetes & Metabolism|February 15, 2020
Fasting and post-oral-glucose-load levels of methylglyoxal are associated with microvascular, but not macrovascular, disease in individuals with and without (pre)diabetes: The Maastricht StudyN M J Hanssen, J L J M Scheijen, A J H M Houben, et al.
Antimicrobial Agents and Chemotherapy|November 13, 2024
Targeted antimicrobial regimens for Gram-negative prosthetic joint infections: a prospective multicenter studyJaap L J Hanssen, Robert J P van der Wal, Rachid Mahdad, et al.
Contemporary Clinical Trials|June 2, 2025
Rifampicin combination therapy versus targeted antimicrobial monotherapy in the oral antimicrobial treatment phase of staphylococcal prosthetic joint infection (RiCOTTA-trial): protocol for a randomized, controlled, open-label, non-inferiority trialJaap L J Hanssen, Esther Y van Hulten, Pieter K Bos, et al.
Circulation Research|June 23, 2020
Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting MyelopoiesisMichelle C Flynn, Michael J Kraakman, Christos Tikellis, et al.
Hepatology Communications|June 11, 2026
Two-step care pathways for advanced MASLD in primary and hospital care: A multicenter studyStan Driessen, Koen C van Son, Tamara R Riemersma, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 16, 2025
Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular DiseaseBernardo Casso-Chapa, Norma Alicia Vazquez González, Nhat-Tu Le, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Downregulation of LATS1/2 Drives Endothelial Senescence-Associated Stemness (SAS) and Atherothrombotic Lesion FormationSivareddy Kotla, Jonghae Lee, Kyung Ae Ko, et al.
Circulation Research|May 27, 2026
LATS1/2-CD38 Metabolic Rewiring Links Senescence to Intraplaque ThrombosisSivareddy Kotla, Jonghae Lee, Kyung Ae Ko, et al.
Pageof 12